Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women

American Journal of Clinical Nutrition

Volumn 96, Issue 6, 2012, Pages 1419-1428

  Schernhammer, Eva S ^a,b,c   Bertrand, Kimberly A ^a,b   Birmann, Brenda M ^a   Sampson, Laura ^b   Willett, Walter C ^a,b   Feskanich, Diane ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTAME; SODIUM CARBONATE; SUGAR; SWEETENING AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; CALORIC INTAKE; CANCER RISK; DENTIST; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FRUIT; HEALTH PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; LEUKEMIA; LIFESTYLE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PHARMACIST; PODIATRIST; POSTMENOPAUSE; PROSPECTIVE STUDY; REGISTERED NURSE; SEX DIFFERENCE; VEGETABLE;

ADULT; ASPARTAME; CARBONATED BEVERAGES; COHORT STUDIES; DIETARY SUCROSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKEMIA; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SEX CHARACTERISTICS; SWEETENING AGENTS; UNITED STATES;

EID: 84869854749     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.030833     Document Type: Article

References (49)

1. US Food and Drug Administration. Aspartame: Commissioner's final decision. Fed Reg 1981;46(142):38285-308.
2. US Food and Drug Administration. Food additives permitted for direct addition to food for human consumption; aspartame. Fed Reg 1984;49(36):6672-82.
3. Tsang WS, Clarke MA, Parrish FW. Determination of aspartame and its breakdown products in soft drinks by reverse-phase chromatography with UV detection. J Agric Food Chem 1985;33(4):734-738.
4. Leth T, Jensen U, Fagt S, Andersen R. Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark, 2005. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2008;25:662-8.
5. Weihrauch MR, Diehl V. Artificial sweeteners-do they bear a carcinogenic risk? Ann Oncol 2004;15:1460-5. (Pubitemid 39409734)
6. Whitehouse CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. AAOHN J 2008;56:251-9, quiz 60-1.
7. Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, et al. Aspartame: review of safety. Regul Toxicol Pharmacol 2002;35:S1-93.
8. Prudel M, Davidkova E, Davidek J, Kminek M. Kinetics of decomposition of aspartame hydrochloride (usal) in aqueous solutions. J Food Sci 1986;51(6):1393-7.
9. International Agency for Research on Cancer Working Group. Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. In: WHO, ed. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, WHO, 2006.
10. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect 2006;114:379-85. (Pubitemid 43338263)
11. European Food Safety Authority EFSA. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame. The EFSA Journal 2009;1015:1-18.
12. Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, Campbell D, Hollenbeck AR, Schatzkin A. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev 2006;15:1654-9. (Pubitemid 44497101)
13. Bosetti C, Gallus S, Talamini R, Montella M, Franceschi S, Negri E, La Vecchia C. Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy. Cancer Epidemiol Biomarkers Prev 2009;18:2235-8.
14. Schernhammer ES, Hu F, Giovannucci E, Michaud DS, Colditz GA, Fuchs C. Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer Epidemiol Biomarkers Prev 2005;14:2098-105. (Pubitemid 41603252)
15. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol 1984;119:837-9. (Pubitemid 14142821)
16. Swerdlow SH, Campo E, Harris NL. WHO classification of tumours if haematopoetic and lymphoid tissues. In: Swerdlow SH, Campo E, Harris NL, eds. Lyon, France: International Agency for Research on Cancer (IARC), 2008.
17. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadie M, Spinelli JJ, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708. (Pubitemid 47105409)
18. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27. (Pubitemid 16095831)
19. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26, discussion 27-36.
20. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6. (Pubitemid 23260170)
21. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 2002;288:2300-6. (Pubitemid 35291760)
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
23. Lee SL, Shih HT, Chi YC, Li YP, Yin SJ. Oxidation of methanol, ethylene glycol, and isopropanol with human alcohol dehydrogenases and the inhibition by ethanol and 4-methylpyrazole. Chem Biol Interact 2011;191:26-31.
24. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990;322:95-9. (Pubitemid 20023867)
25. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 1969;166:386-8.
26. Finkelstein MW, Daabees TT, Stegink LD, Applebaum AE. Correlation of aspartate dose, plasma dicarboxylic amino acid concentration, and neuronal necrosis in infant mice. Toxicology 1983;29:109-19. (Pubitemid 14177274)
27. Daabees TT, Finkelstein MW, Stegink LD, Applebaum AE. Correlation of glutamate plus aspartate dose, plasma amino acid concentration and neuronal necrosis in infant mice. Food Chem Toxicol 1985;23:887-93. (Pubitemid 16201477)
28. Ishii H. Incidence of brain tumors in rats fed aspartame. Toxicol Lett 1981;7:433-7. (Pubitemid 11114700)
29. Nehrling JK, Kobe P, McLane MP, Olson RE, Kamath S, Horwitz DL. Aspartame use by persons with diabetes. Diabetes Care 1985;8:415-7. (Pubitemid 15240901)
30. National Toxicology Program. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies). Natl Toxicol Program Genet Modif Model Rep 2005;1:1-222.
31. Soffritti M, Belpoggi F, Esposti DD, Lambertini L. Aspartame induces lymphomas and leukemias in rats. Eur J Oncol 2005;10:107-16. (Pubitemid 41376642)
32. Karikas GA, Schulpis KH, Reclos G, Kokotos G. Measurement of molecular interaction of aspartame and its metabolites with DNA. Clin Biochem 1998;31:405-7. (Pubitemid 28385241)
33. Bandyopadhyay A, Ghoshal S, Mukherjee A. Genotoxicity testing of low-calorie sweeteners: aspartame, acesulfame-K, and saccharin. Drug Chem Toxicol 2008;31:447-57.
34. Shephard SE, Wakabayashi K, Nagao M. Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation. Food Chem Toxicol 1993;31:323-9. (Pubitemid 23167378)
35. Zhang S, Hunter DJ, Rosner BA, Colditz GA, Fuchs CS, Speizer FE, Willett WC. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 1999;91:1751-8. (Pubitemid 29518771)
36. Soffritti M, Belpoggi F, Cevolanim D, Guarino M, Padovani M, Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann N Y Acad Sci 2002;982:46-69. (Pubitemid 36127071)
37. Soffritti M, Belpoggi F, Lambertin L, Lauriola M, Padovani M, Maltoni C. Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann N Y Acad Sci 2002;982:87-105. (Pubitemid 36127073)
38. Kavet R, Nauss KM. The toxicity of inhaled methanol vapors. Crit Rev Toxicol 1990;21:21-50. (Pubitemid 20283435)
39. Davoli E, Cappellini L, Airoldi L, Fanelli R. Serum methanol concentrations in rats and in men after a single dose of aspartame. Food Chem Toxicol 1986;24:187-9. (Pubitemid 16128936)
40. Canada Health. Available from: www.hc-sc.gc.ca/ewh-semt/pubs/water-eau/ formaldehyde/classification-eval-eng.php (cited 9 February 2011).
41. International Programme on Chemical Safety. Available from: http://www.inchem.org/documents/pims/chemical/pim335.htm (cited 9 February 2011).
42. Sielken RL Jr, Valdez-Flores C. Butadiene cancer exposure-response modeling: Based on workers in the styrene-butadiene-rubber industry: total leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia. Regul Toxicol Pharmacol 2011;60:332-41.
43. Ahmad M, Bajahlan AS. Leaching of styrene and other aromatic compounds in drinking water from PS bottles. J Environ Sci (China) 2007;19:421-6. (Pubitemid 46731313)
44. Monte WC. Methanol: a chemical Trojan horse as the root of the inscrutable U. Med Hypotheses 2010;74:493-6.
45. Chrostek L, Jelski W, Szmitkowski M, Puchalski Z. Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 2003;17:93-6. (Pubitemid 36523414)
46. Parlesak A, Billinger MH, Bode C, Bode JC. Gastric alcohol dehydrogenase activity in man: influence of gender, age, alcohol consumption and smoking in a Caucasian population. Alcohol Alcohol 2002;37:388-93. (Pubitemid 34830919)
47. Hazouard E, Ferrandiere M, Paintaud G, Perrotin D. Delayed toxicity in acute ethanol-methanol copoisoning in a chronic alcohol abuser: usefulness of continuous 4-methylpyrazole (fomepizole) infusion. Intensive Care Med 2000;26:827-8. (Pubitemid 30449690)
48. Smith EN, Taylor RT. Acute toxicity of methanol in the folate-deficient acatalasemic mouse. Toxicology 1982;25:271-87. (Pubitemid 13121225)
49. Cruzan G. Assessment of the cancer potential of methanol. Crit Rev Toxicol 2009;39:347-63.